Antimicrobial stewardship in ICU – Why we need it?
Replay available
The WHO confirms Antimicrobial Resistance (AMR) as a top global public health and development threat. Bacterial AMR was directly responsible for 1.27 million global deaths in 2019 and contributed to 4.95 million deaths. The misuse and overuse of antimicrobials in humans, animals, and plants are responsible for developing drug-resistant pathogens.
Therefore, it is necessary to wisely use antimicrobials and give importance to Antimicrobial Stewardship(AMS). AMS refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance.
We will discuss with our experts the AMS in the Intensive Care environment.
This webinar is organised by the ESICM Infection (INF) Section.
Aims & Objectives
- Discuss the importance of Antimicrobial stewardship of bacterium-mediated infections
- Learn about the Antimicrobial stewardship of fungal-mediated infections
Topics & Speakers
Antimicrobial stewardship bacterium-mediated infections
Paula RAMIREZ
La Fe Hospital, Valencia (SP)
Antimicrobial stewardship fungal mediated infections
Gennaro DE PASCALE
Sacred Heart Catholic University, Rome (IT)
MODERATORS
Hendrik BRACHT
Bethel Protestant Hospital, Bielefeld (DE)